Ultragenyx Pharmaceutical Inc. - Net Worth and Insider Trading
Ultragenyx Pharmaceutical Inc. Net Worth
The estimated net worth of Ultragenyx Pharmaceutical Inc. is at least $27 Million dollars as of 2024-11-10. Ultragenyx Pharmaceutical Inc. is the Director of Arcturus Therapeutics Holdings Inc and owns about 1,400,000 shares of Arcturus Therapeutics Holdings Inc (ARCT) stock worth over $27 Million. Details can be seen in Ultragenyx Pharmaceutical Inc.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ultragenyx Pharmaceutical Inc. has not made any transactions after 2021-08-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ultragenyx Pharmaceutical Inc. owns 2 companies in total, including Arcturus Therapeutics Holdings Inc (ARCT) , and Solid Biosciences Inc (SLDB) .
Click here to see the complete history of Ultragenyx Pharmaceutical Inc.’s form 4 insider trades.
Insider Ownership Summary of Ultragenyx Pharmaceutical Inc.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ARCT | Arcturus Therapeutics Holdings Inc | 2021-08-11 | director & 10 percent owner |
SLDB | Solid Biosciences Inc | 2020-10-22 | 10 percent owner |
Ultragenyx Pharmaceutical Inc. Latest Holdings Summary
Ultragenyx Pharmaceutical Inc. currently owns a total of 1 stock. Ultragenyx Pharmaceutical Inc. owns 1,400,000 shares of Arcturus Therapeutics Holdings Inc (ARCT) as of August 11, 2021, with a value of $27 Million.
Latest Holdings of Ultragenyx Pharmaceutical Inc.
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ARCT | Arcturus Therapeutics Holdings Inc | 2021-08-11 | 1,400,000 | 19.63 | 27,475,000 |
Holding Weightings of Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc. Form 4 Trading Tracker
According to the SEC Form 4 filings, Ultragenyx Pharmaceutical Inc. has made a total of 2 transactions in Arcturus Therapeutics Holdings Inc (ARCT) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Arcturus Therapeutics Holdings Inc is the sale of 800,000 shares on August 11, 2021, which brought Ultragenyx Pharmaceutical Inc. around $44 Million.
Insider Trading History of Ultragenyx Pharmaceutical Inc.
- 1
Ultragenyx Pharmaceutical Inc. Trading Performance
Ultragenyx Pharmaceutical Inc. Ownership Network
Ownership Network List of Ultragenyx Pharmaceutical Inc.
Ownership Network Relation of Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc. Owned Company Details
What does Arcturus Therapeutics Holdings Inc do?
Who are the key executives at Arcturus Therapeutics Holdings Inc?
Ultragenyx Pharmaceutical Inc. is the director & 10 percent owner of Arcturus Therapeutics Holdings Inc. Other key executives at Arcturus Therapeutics Holdings Inc include Chief Scientific Officer & COO Pad Chivukula , Chief Financial Officer Andy Sassine , and See Remarks Keith C Kummerfeld .
Arcturus Therapeutics Holdings Inc (ARCT) Insider Trades Summary
Over the past 18 months, Ultragenyx Pharmaceutical Inc. made no insider transaction in Arcturus Therapeutics Holdings Inc (ARCT). Other recent insider transactions involving Arcturus Therapeutics Holdings Inc (ARCT) include a net sale of 139,114 shares made by Pad Chivukula , a net sale of 50,000 shares made by Andy Sassine , and a net sale of 6,968 shares made by Keith C Kummerfeld .
In summary, during the past 3 months, insiders sold 12,000 shares of Arcturus Therapeutics Holdings Inc (ARCT) in total and bought 0 shares, with a net sale of 12,000 shares. During the past 18 months, 196,082 shares of Arcturus Therapeutics Holdings Inc (ARCT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 196,082 shares.
Arcturus Therapeutics Holdings Inc (ARCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arcturus Therapeutics Holdings Inc Insider Transactions
Ultragenyx Pharmaceutical Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for Ultragenyx Pharmaceutical Inc.. You might contact Ultragenyx Pharmaceutical Inc. via mailing address: 60 Leveroni Court, Novato Ca 94949.